Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Creative Medical Technology Holdings (CELZ) Return on Equity (2016 - 2025)

Historic Return on Equity for Creative Medical Technology Holdings (CELZ) over the last 17 years, with Q3 2025 value amounting to 0.96%.

  • Creative Medical Technology Holdings' Return on Equity fell 2100.0% to 0.96% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.96%, marking a year-over-year decrease of 2100.0%. This contributed to the annual value of 0.66% for FY2024, which is 2600.0% down from last year.
  • According to the latest figures from Q3 2025, Creative Medical Technology Holdings' Return on Equity is 0.96%, which was down 2100.0% from 0.77% recorded in Q2 2025.
  • In the past 5 years, Creative Medical Technology Holdings' Return on Equity registered a high of 29.29% during Q3 2021, and its lowest value of 1.0% during Q1 2022.
  • Over the past 5 years, Creative Medical Technology Holdings' median Return on Equity value was 0.65% (recorded in 2023), while the average stood at 1.68%.
  • Its Return on Equity has fluctuated over the past 5 years, first soared by 283800bps in 2021, then tumbled by -296300bps in 2022.
  • Quarter analysis of 5 years shows Creative Medical Technology Holdings' Return on Equity stood at 3.9% in 2021, then tumbled by -114bps to 0.53% in 2022, then increased by 12bps to 0.47% in 2023, then tumbled by -81bps to 0.85% in 2024, then dropped by -13bps to 0.96% in 2025.
  • Its last three reported values are 0.96% in Q3 2025, 0.77% for Q2 2025, and 0.85% during Q1 2025.